Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (89)Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients
Preheader (123)Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension
Typography
Arial
Colors
Text Analysis
Body Words143
Subject Words14
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px752 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeAfternoon

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension
Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients